381 related articles for article (PubMed ID: 31052499)
41. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.
Francica JR; Varela-Rohena A; Medvec A; Plesa G; Riley JL; Bates P
PLoS Pathog; 2010 Sep; 6(9):e1001098. PubMed ID: 20844579
[TBL] [Abstract][Full Text] [Related]
42. Immune barriers of Ebola virus infection.
McElroy AK; Mühlberger E; Muñoz-Fontela C
Curr Opin Virol; 2018 Feb; 28():152-160. PubMed ID: 29452995
[TBL] [Abstract][Full Text] [Related]
43. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
44. Functional CD8+ T cell responses in lethal Ebola virus infection.
Bradfute SB; Warfield KL; Bavari S
J Immunol; 2008 Mar; 180(6):4058-66. PubMed ID: 18322215
[TBL] [Abstract][Full Text] [Related]
45. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
46. ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.
Han Z; Sagum CA; Bedford MT; Sidhu SS; Sudol M; Harty RN
J Virol; 2016 Oct; 90(20):9163-71. PubMed ID: 27489272
[TBL] [Abstract][Full Text] [Related]
47. Entry of Ebola Virus is an Asynchronous Process.
Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S199-203. PubMed ID: 25941332
[TBL] [Abstract][Full Text] [Related]
48. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
49. Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics.
Kotliar D; Lin AE; Logue J; Hughes TK; Khoury NM; Raju SS; Wadsworth MH; Chen H; Kurtz JR; Dighero-Kemp B; Bjornson ZB; Mukherjee N; Sellers BA; Tran N; Bauer MR; Adams GC; Adams R; Rinn JL; Melé M; Schaffner SF; Nolan GP; Barnes KG; Hensley LE; McIlwain DR; Shalek AK; Sabeti PC; Bennett RS
Cell; 2020 Nov; 183(5):1383-1401.e19. PubMed ID: 33159858
[TBL] [Abstract][Full Text] [Related]
50. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
mBio; 2019 May; 10(3):. PubMed ID: 31138743
[TBL] [Abstract][Full Text] [Related]
51. Camouflage and misdirection: the full-on assault of ebola virus disease.
Misasi J; Sullivan NJ
Cell; 2014 Oct; 159(3):477-86. PubMed ID: 25417101
[TBL] [Abstract][Full Text] [Related]
52. Monitoring Innate Immune Gene Responses in the Hamster Model of Ebola Virus Disease by RT-PCR.
Zivcec M
Methods Mol Biol; 2017; 1628():321-337. PubMed ID: 28573632
[TBL] [Abstract][Full Text] [Related]
53. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
[TBL] [Abstract][Full Text] [Related]
54. Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.
Licata JM; Johnson RF; Han Z; Harty RN
J Virol; 2004 Jul; 78(14):7344-51. PubMed ID: 15220407
[TBL] [Abstract][Full Text] [Related]
55. A cylindrical assembly model and dynamics of the Ebola virus VP40 structural matrix.
Pavadai E; Gerstman BS; Chapagain PP
Sci Rep; 2018 Jun; 8(1):9776. PubMed ID: 29950600
[TBL] [Abstract][Full Text] [Related]
56. The Ebola virus VP40 matrix layer undergoes endosomal disassembly essential for membrane fusion.
Winter SL; Golani G; Lolicato F; Vallbracht M; Thiyagarajah K; Ahmed SS; Lüchtenborg C; Fackler OT; Brügger B; Hoenen T; Nickel W; Schwarz US; Chlanda P
EMBO J; 2023 Jun; 42(11):e113578. PubMed ID: 37082863
[TBL] [Abstract][Full Text] [Related]
57. Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation.
Iampietro M; Santos RI; Lubaki NM; Bukreyev A
J Infect Dis; 2018 Nov; 218(suppl_5):S327-S334. PubMed ID: 30085081
[TBL] [Abstract][Full Text] [Related]
58. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.
Hensley LE; Young HA; Jahrling PB; Geisbert TW
Immunol Lett; 2002 Mar; 80(3):169-79. PubMed ID: 11803049
[TBL] [Abstract][Full Text] [Related]
59. Ebola virus: unravelling pathogenesis to combat a deadly disease.
Hoenen T; Groseth A; Falzarano D; Feldmann H
Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
[TBL] [Abstract][Full Text] [Related]
60. Analysis of a Putative Late Domain Using an Ebola Virus Transcription and Replication-Competent Virus-Like Particle System.
Wendt L; Kämper L; Schmidt ML; Mettenleiter TC; Hoenen T
J Infect Dis; 2018 Nov; 218(suppl_5):S355-S359. PubMed ID: 29931371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
